-
公开(公告)号：EP1246662A1
公开(公告)日：2002-10-09
申请号：EP00984484.6
申请日：2000-12-13
申请人： ALZA Corporation
发明人： FERREIRA, Pamela , DAVIS, Craig, R. , BERRY, Stephen, A. , STEWART, Gregory, R. , MAGRUDER, Judy, A. , LAU, Li-Ming , MAGRUDER, Paul, R. , HARRISON, Juan, M. , ROORDA, Wouter
CPC分类号： A61K9/0024 , A61K9/0004 , A61M37/00
摘要： An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place.
-
公开(公告)号：EP1239840A2
公开(公告)日：2002-09-18
申请号：EP00984181.8
申请日：2000-12-08
申请人： Alza Corporation
CPC分类号： A61K9/0004
摘要： A pharmaceutical composition comprising a liquid antiviral formulation is disclosed. Additionally, a dosage form and a method for administering an antiviral pharmaceutical composition are disclosed.
-
公开(公告)号：EP1246662B1
公开(公告)日：2005-08-31
申请号：EP00984484.6
申请日：2000-12-13
申请人： ALZA CORPORATION
发明人： FERREIRA, Pamela , DAVIS, Craig, R. , BERRY, Stephen, A. , STEWART, Gregory, R. , MAGRUDER, Judy, A. , LAU, Li-Ming , MAGRUDER, Paul, R. , HARRISON, Juan, M. , ROORDA, Wouter
CPC分类号： A61K9/0024 , A61K9/0004 , A61M37/00
摘要： An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place.
-
公开(公告)号：EP1239840B1
公开(公告)日：2005-04-06
申请号：EP00984181.8
申请日：2000-12-08
申请人： Alza Corporation
CPC分类号： A61K9/0004
摘要： A pharmaceutical composition comprising a liquid antiviral formulation is disclosed. Additionally, a dosage form and a method for administering an antiviral pharmaceutical composition are disclosed.
-
-
-
搜索结果
4 条记录 (耗时 0.007 秒)
